Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients

OBJECTIVE: This prospective, post-marketing study collected sunitinib safety and efficacy data in Japanese patients with unresectable/metastatic renal cell carcinoma. Retrospective analysis investigated adverse events as potential sunitinib efficacy biomarkers. METHODS: Patients administered sunitin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Jpn J Clin Oncol
Egile Nagusiak: Akaza, Hideyuki, Naito, Seiji, Ueno, Naomi, Aoki, Kouji, Houzawa, Hiroyuki, Pitman Lowenthal, Susan, Lee, Sang-Yoon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2015
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461239/
https://ncbi.nlm.nih.gov/pubmed/25917359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv045
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak